TRI 5.26% 2.0¢ trivarx ltd

Ann: Completion of Phase 2 SAMDE Trial, page-9

  1. 280 Posts.
    lightbulb Created with Sketch. 134
    AAAAAANNNNND my fill is complete!

    Keen to see these results!

    Looking at this from a logical point of view, the study makes sense.

    IMO, this has the potential to identify not only SAMDE, but also the potential to identify what may be an underlying cause of certain sleep disorders!

    The ability to commercialise this technology with wearable devices brings rise to SH profits as well.

    Ideally, we want to be bought out!

    Don't we love making money on good products?


    GLTAH & DYOR!!!
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.